Log in to save to my catalogue

Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic cast...

Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic cast...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8548293

Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial

About this item

Full title

Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial

Publisher

London: Nature Publishing Group UK

Journal title

British journal of cancer, 2021-10, Vol.125 (9), p.1226-1232

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background
In a Phase 2 clinical trial, we aimed to determine the lutetium-177 [
177
Lu]-PSMA-617 activity and the clinical utility of levels of plasma androgen receptor (AR) gene in patients with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC).
Methods
We determined AR copy number in pretreatment plasma sa...

Alternative Titles

Full title

Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8548293

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8548293

Other Identifiers

ISSN

0007-0920

E-ISSN

1532-1827

DOI

10.1038/s41416-021-01508-5

How to access this item